108 related articles for article (PubMed ID: 2251876)
1. Development of a new type of influenza subunit vaccine made by muramyldipeptide-liposome: enhancement of humoral and cellular immune responses.
Nerome K; Yoshioka Y; Ishida M; Okuma K; Oka T; Kataoka T; Inoue A; Oya A
Vaccine; 1990 Oct; 8(5):503-9. PubMed ID: 2251876
[TBL] [Abstract][Full Text] [Related]
2. Characteristics of cytotoxic T lymphocytes directed to influenza virus haemagglutinin elicited by immunization with muramyldipeptide-influenza liposome vaccine.
Iinuma H; Nerome K; Yoshioka Y; Okinaga K
Scand J Immunol; 1995 Jan; 41(1):1-10. PubMed ID: 7824883
[TBL] [Abstract][Full Text] [Related]
3. Preparation of influenza virosome vaccine with muramyldipeptide derivative B30-MDP.
Ando S; Tsuge H; Mayumi T
J Microencapsul; 1997; 14(1):79-90. PubMed ID: 8994077
[TBL] [Abstract][Full Text] [Related]
4. Phase 1 clinical tests of influenza MDP-virosome vaccine (KD-5382).
Kaji M; Kaji Y; Kaji M; Ohkuma K; Honda T; Oka T; Sakoh M; Nakamura S; Kurachi K; Sentoku M
Vaccine; 1992; 10(10):663-7. PubMed ID: 1523876
[TBL] [Abstract][Full Text] [Related]
5. Mouse response to influenza immunosomes.
Boudreault A; Thibodeau L
Vaccine; 1985 Sep; 3(3 Suppl):231-4. PubMed ID: 4060853
[TBL] [Abstract][Full Text] [Related]
6. A novel influenza subunit vaccine composed of liposome-encapsulated haemagglutinin/neuraminidase and IL-2 or GM-CSF. II. Induction of TH1 and TH2 responses in mice.
Babai I; Samira S; Barenholz Y; Zakay-Rones Z; Kedar E
Vaccine; 1999 Mar; 17(9-10):1239-50. PubMed ID: 10195637
[TBL] [Abstract][Full Text] [Related]
7. A novel influenza subunit vaccine composed of liposome-encapsulated haemagglutinin/neuraminidase and IL-2 or GM-CSF. I. Vaccine characterization and efficacy studies in mice.
Babai I; Samira S; Barenholz Y; Zakay-Rones Z; Kedar E
Vaccine; 1999 Mar; 17(9-10):1223-38. PubMed ID: 10195636
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxic T cell lysis of target cells fused with liposomes containing influenza virus haemagglutinin and neuraminidase.
Stitz L; Huang RT; Hengartner H; Rott R; Zinkernagel RM
J Gen Virol; 1985 Jun; 66 ( Pt 6)():1333-9. PubMed ID: 3874262
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of immunogenicity of a virosome-based avian influenza vaccine in chickens by incorporating CpG-ODN.
Mallick AI; Parvizi P; Read LR; Nagy E; Behboudi S; Sharif S
Vaccine; 2011 Feb; 29(8):1657-65. PubMed ID: 21195078
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of humoral immune responses against viral vaccines by a non-pyrogenic 6-O-acylmuramyldipeptide and synthetic low toxicity analogues of lipid A.
Tsujimoto M; Kotani S; Okunaga T; Kubo T; Takada H; Kubo T; Shiba T; Kusumoto S; Takahashi T; Goto Y
Vaccine; 1989 Feb; 7(1):39-48. PubMed ID: 2718605
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant activity of 6-O-acyl-muramyldipeptides to enhance primary cellular and humoral immune responses in guinea pigs: dose-response and local reactions observed with selected compounds.
Tsujimoto M; Kotani S; Shiba T; Kusumoto S
Infect Immun; 1986 Sep; 53(3):517-21. PubMed ID: 3744549
[TBL] [Abstract][Full Text] [Related]
12. Intranasal immunization with liposome-encapsulated plasmid DNA encoding influenza virus hemagglutinin elicits mucosal, cellular and humoral immune responses.
Wang D; Christopher ME; Nagata LP; Zabielski MA; Li H; Wong JP; Samuel J
J Clin Virol; 2004 Dec; 31 Suppl 1():S99-106. PubMed ID: 15567101
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of immunoglobulin G responses in mice against hepatitis B virus surface antigen, influenza virus hemagglutinin vaccine, and tetanus toxoid by 6-O-acylated muramyl dipeptides.
Furuya T; Kumazawa Y; Takimoto H; Nagumo T; Watanabe M; Aizawa C; Kiso M; Hasegawa A; Nomoto K
Infect Immun; 1989 Jun; 57(6):1839-44. PubMed ID: 2722242
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant activity of 6-O-acyl-muramyldipeptides to enhance primary cellular and humoral immune responses in guinea pigs: adaptability to various vehicles and pyrogenicity.
Tsujimoto M; Kotani S; Kinoshita F; Kanoh S; Shiba T; Kusumoto S
Infect Immun; 1986 Sep; 53(3):511-6. PubMed ID: 3744548
[TBL] [Abstract][Full Text] [Related]
15. Enhanced Influenza Virus-Like Particle Vaccination with a Structurally Optimized RIG-I Agonist as Adjuvant.
Beljanski V; Chiang C; Kirchenbaum GA; Olagnier D; Bloom CE; Wong T; Haddad EK; Trautmann L; Ross TM; Hiscott J
J Virol; 2015 Oct; 89(20):10612-24. PubMed ID: 26269188
[TBL] [Abstract][Full Text] [Related]
16. A new intranasal influenza vaccine based on a novel polycationic lipid--ceramide carbamoyl-spermine (CCS) I. Immunogenicity and efficacy studies in mice.
Joseph A; Itskovitz-Cooper N; Samira S; Flasterstein O; Eliyahu H; Simberg D; Goldwaser I; Barenholz Y; Kedar E
Vaccine; 2006 May; 24(18):3990-4006. PubMed ID: 16516356
[TBL] [Abstract][Full Text] [Related]
17. Biological studies of lipophilic MDP-derivatives incorporated in liposomes.
Jolivet M; Sache E; Audibert F
Immunol Commun; 1981; 10(6):511-22. PubMed ID: 7319546
[TBL] [Abstract][Full Text] [Related]
18. A type-specific avian influenza virus subunit vaccine for turkeys: induction of protective immunity to challenge infection.
Kodihalli S; Sivanandan V; Nagaraja KV; Shaw D; Halvorson DA
Vaccine; 1994 Nov; 12(15):1467-72. PubMed ID: 7887025
[TBL] [Abstract][Full Text] [Related]
19. Influenza virosome/DNA vaccine complex as a new formulation to induce intra-subtypic protection against influenza virus challenge.
Kheiri MT; Jamali A; Shenagari M; Hashemi H; Sabahi F; Atyabi F; Saghiri R
Antiviral Res; 2012 Sep; 95(3):229-36. PubMed ID: 22809863
[TBL] [Abstract][Full Text] [Related]
20. Liposomes enhance the immunogenicity of reconstituted influenza virus A/PR/8 envelopes and the formation of protective antibody by influenza virus A/Sichuan/87 (H3N2) surface antigen.
Gregoriadis G; Tan L; Ben-Ahmeida ET; Jennings R
Vaccine; 1992; 10(11):747-53. PubMed ID: 1441730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
